Latest Articles
- Bioterrorism: What practicing physicians can do
Given the specter of biological terrorism, the medical system has much to learn and much to do to prepare.
Our new understanding of pulmonary alveolar proteinosis: What an internist needs to knowRecent advances point to a defect in granulocyte-macrophage colony stimulating factor (GM-CSF) as a cause of this disease. New treatments are under study.
- Cox - 2 Inhibitors and Cardiovascular Risk
Our study had limitations, but we believe our hypothesis is plausible, our methods were valid, and our conclusions are sound.
- Recognizing and treating diabetic autonomic neuropathy
Strict glycemic control can slow the onset of diabetic autonomic neuropathy and sometimes reverse it. Other treatments address specific symptoms.
- Chronic myelogenous leukemia: The news you have and haven’t heard
One major advance in treating CML was widely publicized. Another, although equally important, was not.
- COX-2 inhibitors: Balancing the hope, the hype, and the concern
When all is said and done, the choice rests with the individual prescribing physician.
- Role of alendronate and risedronate in preventing and treating osteoporosis
A review of the efficacy and use of the two oral bisphosphonates approved for preventing and treating osteoporosis.
- Management of primary headache: Serendipity and science
A capsule summary of the current management of migraine, chronic tension headache, and cluster headache.